Aseptic filling machine operator holding a finished vial filled with liquid drug product. Vanrx's robotic sterile filling systems help pharmaceutical companies bring drug products to market faster.

Bring drug products to market faster

Faster to market

Flexible pharmaceutical filling machine for vials, syringes and cartridges

Using Vanrx Workcells, pharmaceutical companies can bring injectable medicines to market faster. Short changeover times and flexible systems enable agile manufacturing.

Aseptic filling for personalized medicines

Aseptic Filling for Personalized Medicines describes a new solution for the aseptic filling of cell and gene therapies, immuno-oncology, mRNA and other modalities where manufacturing creates a therapy for a single patient.

Download the white paper

Bring new drug products to market faster

October 15, 2018 - Blog, Featured

In a June 2018 interview with McKinsey & Company, Esteban Santos, executive vice president for operations at Amgen, described the current state of the biopharma market and the resulting need for companies to bring new drug products to market faster. This blog will explore how Vanrx’s aseptic processing machines can accelerate drug development, build facilities faster and respond faster to changing market conditions.

Read More

The future is gloveless for biopharma aseptic filling

September 25, 2018 - Article, Featured

Vanrx was recently featured in the leading international publication Cleanroom Technology for redesigning the aseptic filling process with our gloveless isolator technology. This article explains how the future of aseptic filling is shifting away from glove ports / conventional isolators and focusing on gloveless isolators, such as Vanrx Aseptic Filling Workcells. The built-in flexibility and aseptic assurance provided by these new aseptic filling technologies are a global solution for changing pharmaceutical market demands.

Read More

 

Video case study: Singota Solutions

Singota Solutions recognized a gap in the market for contract aseptic filling services. They realized that companies developing new drug products and needing to fill batches of 20,000 units or less were underserved by contract manufacturing organizations. They chose Vanrx’s SA25 Aseptic Filling Workcell to provide an agile filling service for vials, syringes and cartridges, with short lead times.

Read the case study

Manual aseptic processing needs to end

September 7, 2018 - Blog, cell therapy, Featured, Gene therapy

Manual aseptic processing is definitely not the best approach— it’s the last resort. Vanrx would go a step further and suggest that manual aseptic processing should end. The technologies and process understanding exist to do away with operator-driven aseptic technique.

Read More

Pharmaceutical industry transitioning to press-fit vial closures

September 5, 2018 - Blog, Featured, Innovation

Press-fit closures for pharmaceutical vials provide a number of benefits for container-closure integrity, manufacturing and marketing differentiation. This blog reviews the benefits of these closures in replacing aluminum crimp caps.

Read More

Upcoming events

PDA Cell & Gene Therapy Conference

Oct 23 - Oct 24, 2018

Bethesda, MD, USA

Table #7

ISPE Annual Meeting

Nov 5 - Nov 7, 2018

Philadelphia, PA, USA

981

ISPE Biopharmaceutical Manufacturing Conference

Dec 10 - Dec 12, 2018

Huntington Beach, CA, USA

401

A New Paradigm for Manufacturing Injectable Medicines

Get a detailed view of how Aseptic Filling Workcells compare to conventional technologies and help bring drug products to market faster.

Download the white paper

Vanrx came from biopharma

Our team members have developed and brought complex drug products to market. We know what you need now, and are designing for the future.